| ROK |
Report |
Fiscal Q3 2026 adjusted EPS |
BEAT |
pred ~$3.48 vs. cons $3.38 |
MEDIUM |
| ROK |
Report |
Fiscal Q3 2026 reported sales |
BEAT |
pred ~$2.27B vs. cons $2.24B |
MEDIUM |
| ROK |
Report |
Fiscal Q3 2026 enterprise operating margin |
BEAT |
pred ~22.8% vs. cons 22.5% |
LOW |
| ROK |
Guide |
Adjusted EPS guidance midpoint |
BETTER |
guide ~$13.15 vs. cons $13.03 (fiscal 2026) |
MEDIUM |
| ROK |
Guide |
Reported sales guidance midpoint |
UNCHANGED |
guide ~$9.00B vs. cons $9.00B (fiscal 2026) |
MEDIUM |
| ROK |
Guide |
Enterprise operating margin guidance |
BETTER |
guide ~21.8% vs. cons 21.7% (fiscal 2026) |
LOW |
| ROK |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.0% |
— |
MEDIUM |
| ROK |
Return |
5-day cumulative residual |
+1.8% (STABILIZE) |
A ~3.0% day-1 residual stabilizes near ~1.8% by day 5: the quarter should beat, but fiscal-2026 guidance implies roughly $3.62 of Q4 adjusted EPS versus approximately $3.64 consensus, limiting out-period estimate revisions despite stronger full-year guidance. |
MEDIUM |